SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-052389
Filing Date
2019-10-02
Accepted
2019-10-02 07:06:10
Documents
3
Period of Report
2019-10-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-19345_18k.htm 8-K 26078
2 EX-99.1 a19-19345_1ex99d1.htm EX-99.1 23811
3 GRAPHIC g193451mmi001.jpg GRAPHIC 2594
  Complete submission text file 0001104659-19-052389.txt   54677
Mailing Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038
Business Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 191130746
SIC: 2834 Pharmaceutical Preparations